sábado, 21 de mayo de 2022

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

No hay comentarios:

Publicar un comentario